Riches in Zeneca drugs pipeline; The Investment Column

Few could have guessed that shares in Zeneca would triple in the space of under four years, but since the spin-off from ICI, Britain's third-biggest drugs group has developed a reputation as one of the best on the market. The question for investors is to what extent the current price reflects long-running hopes that Roche or some other deep-pocketed rival may pounce and how much it is a measure of fundamental prospects. The former seemed to be gaining the upper hand yesterday, with the shares dipping 42p to pounds 18.605 on profit-taking and gripes that the company's new drugs pipeline was looking a little empty.

That looks churlish for a company which churned out a 15 per cent rise in underlying profits before exceptionals of pounds 1.01bn in the year to December. More so when you add in Zeneca's "aspirational target" of achieving 15 per cent a year average earnings growth over the next five years.

There was little to quibble about in last year's figures. More than 14 per cent of the underlying sales growth in the main pharmaceuticals business to pounds 2.44bn came from products launched in the past two years. The cost of developing and launching these products is holding back profits, up an underlying 6 per cent to pounds 757m in the division, but the prospects are encouraging. Casodex, the prostate cancer treatment, saw sales jump from pounds 10m to pounds 68m and now claims a 45 per cent share of the US prescriptions market. Arimidex, the breast cancer drug, managed pounds 20m sales from a standing start last year, while Accolate, Zeneca's delayed entry into the asthma market, is said to be doing better than Glaxo's rival Flovent.

The group is also excited about the prospects for Zomig, the migraine treatment acquired from Glaxo last year. News that Zomig has won its first official approval, from the UK, will pit it against Glaxo's rival Naramig product, which has also just gained its first clearance, from Sweden.

But this is a big market and both Zomig and the Seroquel schizophrenia drug to be launched later this year are set to achieve peak sales well in excess of pounds 200m.

These and other launches should tide the group over any temporary gap in drugs in late-stage trials, while further out, some of the 18 products in the development pipeline will come good. The company can also use its pounds 272m net cash to plug any holes: Zestril, the group's best-selling heart drug, was after all acquired from Merck.

Currency could hit this year's figures, so profits of pounds 1.1bn would put the shares on a heady forward multiple of 24, but by 1998 that could have fallen to 20, in line with SmithKline Beecham and Glaxo. Hold on.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

SThree: Talent Acquisition Consultant

£22500 - £27000 per annum + OTE £45K: SThree: Since our inception in 1986, STh...

Day In a Page

John Palmer: 'Goldfinger' of British crime was murdered, say police

Murder of the Brink’s-MAT mastermind

'Goldfinger' of British crime's life ended in a blaze of bullets, say police
Forget little green men - aliens will look like humans, says Cambridge University evolution expert

Forget little green men

Leading evolutionary biologist says aliens will look like humans
The Real Stories of Migrant Britain: An Algerian scientist adjusts to life working in a kebab shop

The Real Stories of Migrant Britain

An Algerian scientist struggles to adjust to her new life working in a Scottish kebab shop
Bodyworlds museum: Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy

Dying dream of Doctor Death

Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy
UK heatwave: Temperature reaches 39.8 degrees on Central Line - the sweatiest place in London

39.8 degrees recorded on Tube

There's hot (London) and too damn hot (the Underground). Simon Usborne braved the Central line to discover what its passengers suffer
Kitchens go hi-tech: From robot chefs to recipe-shopping apps, computerised cooking is coming

Computerised cooking is coming

From apps that automatically make shopping lists from your recipe books to smart ovens and robot chefs, Kevin Maney rounds up innovations to make your mouth water
Jessie Cave interview: The Harry Potter star has published a feminist collection of cartoons

Jessie Cave's feminist cartoons

The Harry Potter star tells Alice Jones how a one-night stand changed her life
Football Beyond Borders: Even the most distruptive pupils score at homework club

Education: Football Beyond Borders

Add football to an after-school homework club, and even the naughtiest boys can score
10 best barbecue books

Fire up the barbie: 10 best barbecue books

We've got Bibles to get you grilling and smoking like a true south American pro
Wimbledon 2015: Nick Bollettieri - Junk balls and chop and slice are only way 5ft 1in Kurumi Nara can live with Petra Kvitova’s power

Nick Bollettieri's Wimbledon Files

Junk balls and chop and slice are only way 5ft 1in Kurumi Nara can live with Petra Kvitova’s power
Ron Dennis exclusive: ‘This is one of the best McLaren teams ever – we are going to do it’

‘This is one of the best McLaren teams ever – we are going to do it’

Ron Dennis shrugs off a poor start to the season in an exclusive interview, and says the glory days will come back
Seifeddine Rezgui: What motivated a shy student to kill 38 holidaymakers in Tunisia?

Making of a killer

What motivated a shy student to kill 38 holidaymakers in Tunisia?
UK Heatwave: Temperatures on the tube are going to exceed the legal limit for transporting cattle

Just when you thought your commute couldn't get any worse...

Heatwave will see temperatures on the Tube exceed legal limit for transporting cattle
Exclusive - The Real Stories of Migrant Britain: Swapping Bucharest for London

The Real Stories of Migrant Britain

Meet the man who swapped Romania for the UK in a bid to provide for his family, only to discover that the home he left behind wasn't quite what it seemed
Cheaper energy on the way, but it's not all sunshine and rainbows

Cheaper energy on the way, but it's not all sunshine and rainbows

Solar power will help bring down electricity prices over the next five years, according to a new report. But it’s cheap imports of ‘dirty power’ that will lower them the most